Tilray CEO: Opportunities in medical cannabis are immense
Tilray’s stock is up this day, nevertheless silent down 80 p.c from a February high. CNBC’s Frank Holland reports on his conversation with Tilray CEO Irwin Simon regarding the company’s…
Tilray’s stock is up this day, nevertheless silent down 80 p.c from a February high. CNBC’s Frank Holland reports on his conversation with Tilray CEO Irwin Simon regarding the company’s…